EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 51 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $150,000 | -29.6% | 18,450 | -17.0% | 0.01% | -30.0% |
| Q2 2020 | $213,000 | +100.9% | 22,226 | +42.5% | 0.02% | +53.8% |
| Q1 2020 | $106,000 | -38.7% | 15,592 | +34.5% | 0.01% | -13.3% |
| Q4 2019 | $173,000 | +44.2% | 11,592 | -1.3% | 0.02% | +25.0% |
| Q3 2019 | $120,000 | -7.7% | 11,742 | -4.5% | 0.01% | -7.7% |
| Q2 2019 | $130,000 | -27.4% | 12,292 | -3.9% | 0.01% | -31.6% |
| Q1 2019 | $179,000 | -6.3% | 12,792 | -33.9% | 0.02% | -24.0% |
| Q1 2018 | $191,000 | +67.5% | 19,350 | +87.0% | 0.02% | +66.7% |
| Q3 2017 | $114,000 | – | 10,350 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vivo Capital, LLC | 1,787,091 | $20,462,000 | 6.02% |
| INTERWEST VENTURE MANAGEMENT CO | 1,599,592 | $18,315,000 | 3.89% |
| NEXTHERA CAPITAL LP | 263,600 | $3,018,000 | 1.54% |
| SPHERA FUNDS MANAGEMENT LTD. | 385,301 | $4,412,000 | 0.86% |
| RA Capital Management | 354,200 | $4,056,000 | 0.50% |
| DAFNA Capital Management LLC | 35,977 | $412,000 | 0.35% |
| Boxer Capital, LLC | 138,331 | $1,584,000 | 0.35% |
| SABBY MANAGEMENT, LLC | 238,907 | $2,735,000 | 0.15% |
| Monashee Investment Management LLC | 31,500 | $361,000 | 0.14% |
| Lombard Odier Asset Management (USA) Corp | 100,000 | $1,145,000 | 0.11% |